HISUN PHARM HANGZHOU vs Medline Industries, LP: FDA Enforcement Comparison

Medline Industries, LP has been the subject of 271 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for HISUN PHARM HANGZHOU.

HISUN PHARM HANGZHOU: 0 warning letters, 0 recalls, 1 approval record, 0 Form 483s.

Medline Industries, LP: 0 warning letters, 271 recalls, 0 approval records, 0 Form 483s.

Side by side

HISUN PHARM HANGZHOU — Warning letters0

Medline Industries, LP — Warning letters0

HISUN PHARM HANGZHOU — Recalls0

Medline Industries, LP — Recalls271

HISUN PHARM HANGZHOU — Approval records1

Medline Industries, LP — Approval records0

HISUN PHARM HANGZHOU — Form 483s0

Medline Industries, LP — Form 483s0

Timeline

HISUN PHARM HANGZHOU

Most recent FDA action: July 23, 2026

Full history →

Medline Industries, LP

Most recent FDA action: July 22, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"HISUN PHARM HANGZHOU vs Medline Industries, LP: FDA Enforcement Comparison." Argus HQ, accessed July 29, 2026. https://argushq.ai/compare/hisun-pharm-hangzhou-vs-medline-industries-lp

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗